EP3972604
A BRUTON'S TYROSINE KINASE INHIBITOR FOR USE IN THE TREATMENT OF CHRONIC SPONTANEOUS URTICARIA
:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á Íslandi:
20.5.2020:
4.6.2025:
20729204.6
:
19.5.2040:
19.5.2026
:
A BRUTON'S TYROSINE KINASE INHIBITOR FOR USE IN THE TREATMENT OF CHRONIC SPONTANEOUS URTICARIA
20.5.2020
4.6.2025
19.5.2026
:
Novartis AG:
Lichtstrasse 35, 4056 Basel, CH
:
BHATTACHARYA, Souvik:
Cambridge, Massachusetts 02139, US
:
BIETH, Bruno:
4002 Basel, CH
:
CABANSKI, Maciej:
4002 Basel, CH
:
CENNI, Bruno:
4002 Basel, CH
:
DE BUCK, Stefan:
4002 Basel, CH
:
KAUL, Martin:
4002 Basel, CH
:
KINHIKAR, Arvind:
Cambridge, Massachusetts 02139, US
:
RADIVOJEVIC, Andrijana:
East Hanover, New Jersey 07936, US
:
SEVERIN, Thomas:
4002 Basel, CH
:
STORIM, Julian:
4002 Basel, CH
:
VITALITI GARAMI, Alessandra:
4002 Basel, CH
:
201962851996 P:
23.5.2019:
US
:
IB2020054755:
20.5.2020
:
A61K 31/505, A61P 17/00, A61P 37/08